Publications

July 2016 (Revised July 2019)
Teaching Plan

Doctor My Eyes: The Acquisition of Bausch & Lomb by Warburg Pincus (A)

By: Nori Gerardo Lietz and Ricardo Andrade

In early 2010, senior partners at Warburg Pincus met to review a report on Bausch & Lomb Incorporated, the firm's largest investment at the time. Warburg Pincus had led a group of investors in acquiring Bauch & Lomb on October 26, 2007, taking the company private and... View Details

Keywords: Health Care; Mergers ＆ Acquisitions; Governance; Buyout; Private Equity; Finance; Mergers and Acquisitions; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States

April 2016 (Revised July 2019)
Case

"Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (A)

By: Nori Gerardo Lietz

In early 2010, senior partners at Warburg Pincus met to review a report on Bausch & Lomb Incorporated, the firm's largest investment at the time. Warburg Pincus had led a group of investors in acquiring Bauch & Lomb on October 26, 2007, taking the company private and... View Details

Keywords: Health Care; Mergers ＆ Acquisitions; Governance; Buyout; Private Equity; Finance; Mergers and Acquisitions; Corporate Governance; Health Care and Treatment; Reports; Business Model; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States

August 2003
Teaching Note

Pharmacyclics: Financing Research and Development (TN)

By: Malcolm P. Baker and Richard S. Ruback

Teaching Note for (9-201-056). View Details

Keywords: Pharmaceutical Industry; Pharmaceutical Industry

July 2014 (Revised February 2015)
Teaching Note

Johnson & Johnson: The Promotion of Wellness

By: John A. Quelch

The chief medical officer of Johnson & Johnson (J & J) is reflecting on forty years of sustained efforts by the company to improve employee wellness. The case reviews J & J's multiple wellness initiatives and efforts to measure their effectiveness. It also invites... View Details

Keywords: Empoylee Wellness Programs; Human Resource Management; Corporate Management Strategy; Employee Engagement; Human Resources; Management; Organizations; Performance; Personal Development and Career; Programs; Strategy; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; North and Central America; Europe; Asia

23 May 2000
Research & Ideas

Minding the Muse: The Impact of Downsizing on Corporate Creativity

pharmaceutical firms that rely on creativity," she says. "Today's fast-changing global markets place increased pressure on companies of every kind to continuously create new products, services, and competitive strategies if they... View Details

Keywords: by Peter K. Jacobs

2018
Working Paper

Information Provision and Innovation: Natural Experiment of Herbal Patent Prior Art Adoption at the United States and European Patent Offices

By: Prithwiraj Choudhury and Tarun Khanna

We exploit a natural experiment to study how codifying information about prior innovation affects subsequent innovation. A codified database of traditional Indian herbal formulations was adopted by the European Patent Office (EPO) and the U.S. Patent and Trademark... View Details

Keywords: Patents; Plant-Based Agribusiness; Ethnicity; Health Care and Treatment; Pharmaceutical Industry; Pharmaceutical Industry; China; India

Read Now

December 2010 (Revised April 2012)
Background Note

Stalemate at the WTO: TRIPS, Agricultural Subsidies, and the Doha Round

By: Arthur A. Daemmrich

This note analyzes disputes over intellectual property enforcement and agricultural trade barriers at the center of the Doha Round of World Trade Organization (WTO) negotiations. Fundamental principles of intellectual property rights and agricultural subsidies are... View Details

Keywords: Agribusiness; Trade; Globalization; Governance; International Relations; Intellectual Property; Agreements and Arrangements; Pharmaceutical Industry; Pharmaceutical Industry

05 May 2015
First Look

First Look: May 5

methodology using a novel dataset developed with the division of a large pharmaceutical firm. The dataset consists of all components in the enterprise architecture, the observed dependencies between them, and estimated costs of change for... View Details

Keywords: Carmen Nobel

03 Jan 2007
First Look

First Look: January 3, 2007

analysts from Gradient Analytics and Banc of America face charges of stock price manipulation from Biovail, a Canadian pharmaceutical company. Gradient and BofA produced negative reports on Biovail's earnings quality. At the same time,... View Details

Keywords: Sean Silverthorne

19 Sep 2012
Research & Ideas

Funding Innovation: Is Your Firm Doing it Wrong?

the scale and resources of the corporate lab with some of the intensity and urgency associated with the venture capital model, you have something that can be very, very strong," Lerner says. The book describes how, in 2008, the View Details

Keywords: by Carmen Nobel

12 Feb 2019
First Look

New Research and Ideas, February 12, 2019

its 150th anniversary? Purchase this case:https://cb.hbsp.harvard.edu/cbmp/product/319046-PDF-ENG Harvard Business School Case 318-005 Dr. William Carson—Intrapreneurial Innovation in the Pharmaceutical Industry Dr. William Carson, an... View Details

Keywords: Dina Gerdeman

April 2022
Teaching Note

CVS Health: Prescription for Transformation

By: Rosabeth Moss Kanter and Catarina Martinez

In 2021, new CEO Karen Lynch (named the most powerful woman in business) considered the next transformation phase for CVS Health (a Fortune 5 corporate giant). The 2018 acquisition of Aetna insurance brought her to the company as part of its long evolution from a... View Details

Keywords: Health; COVID-19 Pandemic; Primary Care; Leadership; Change Management; Women Executives; Retail; Pharmacy; Pharmacy Benefit Manager; Clinical Trials; Vaccination; Acquisition; Innovation and Invention; Transformation; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States

May 2018
Case

The Multiple Myeloma Research Foundation's Answer Fund

By: Richard G. Hamermesh and Matthew G. Preble

December 2017 (Revised January 2018)
Case

Alltech

By: David E. Bell and Natalie Kindred

Alltech was a Lexington, Kentucky–based producer of supplements for animal feed, with revenues of over $2 billion (projected to reach $3 billion in 2018), sales in 120 countries, 5,000 employees, and 100 manufacturing plants worldwide. For nearly four decades, Alltech... View Details

July 1981 (Revised December 1984)
Case

American Distilling Co. (A)

By: William E. Fruhan Jr.

Keywords: Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry

Find at Harvard

June 2010 (Revised February 2013)
Background Note

The Precautionary Principle

By: Michael W. Toffel and Nazli Z. Uludere Aragon

This note describes the precautionary principle and its key tenets, highlights challenges associated with its use, and includes many examples of its application, primarily within the realm of regulating activities based on the risk of harm to human health and the... View Details

Keywords: Governing Rules, Regulations, and Reforms; Policy; Health Disorders; Business and Government Relations; Safety; Natural Environment; Pollutants; Agriculture and Agribusiness Industry; Chemical Industry; Pharmaceutical Industry

06 Aug 2001
Research & Ideas

Go Global—or No? Can You Make the Case?

Remember, we don't yet have the capability to serve the chemical and pharmaceutical industries here. There are still only 38 of us, and I estimate that building the support infrastructure we need just for domestic expansion could cost as... View Details

Keywords: by Walter Kuemmerle

November 2006
Case

Competitive Headaches (A): The Analgesic Wars

By: Dennis A. Yao

Addresses the problem of competing with a me-too consumer product. Focuses on Bristol-Meyers' 1975 strategy for introducing a competitor to Tylenol in the analgesic market. View Details

Keywords: Market Entry and Exit; Competition; Competitive Advantage; Pharmaceutical Industry; Pharmaceutical Industry